Cord Blood America, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2017
August 11, 2017 at 08:30 am EDT
Share
Cord Blood America, Inc. reported earnings results for the second quarter ended June 30, 2017. For the quarter, the company reported total revenue of $0.75 million, a decrease of 5.9% from total revenue of $0.79 million for the second quarter 2016. EBITDA was $0.20 million, an increase of 151.9% from EBITDA of $0.08 million for the second quarter 2016. Net income was $0.15 million compared to a loss of $0.03 million in second quarter 2016.
CBA Florida, Inc., formerly Cord Blood America, Inc., through its CorCell program and its subsidiary CorCell Companies, Inc., provides cord blood and cord tissue stem cell services. The Company's subsidiaries include Cord Partners, Inc., CorCell Companies, Inc., CorCell, Ltd., (Cord Partners, Inc., CorCell Companies, Inc. and CorCell, Ltd. are referred to collectively as Cord), CBA Properties, Inc. (Properties), and Career Channel, Inc. The Company and its subsidiaries provides private cord blood and cord tissue stem cell storage services to families throughout the United States and Puerto Rico, and Properties was formed to hold corporate trademarks and other intellectual property. Cord's operations provide umbilical cord blood banking and cord tissue services to expectant parents. Cord provides various services, which includes collection materials, physician and customer support, transportation, testing and cord blood storage.
CBA FLORIDA, INC. 
